Kioxia Says US ADR Listing Reports Not Authorized by Company

The denial is narrow: Kioxia is disputing authorization of the reports, not ruling out a US listing, and it explicitly leaves timing, venue and issuance method undetermined. That distinction matters because a chipmaker of this scale sits close to the memory supply chain that underpins AI infrastructure, so any listing signal gets read as a capital-markets event for the sector rather than a company story. The open question is whether the company moves from denying reports to formally confirming a structure, or lets the speculation fade.